MS patients in England to benefit from major roll out of take-at-home pill

Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments

Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.

Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.